BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Constantin C, Pisani A, Bardi G, Neagu M. Nano-carriers of COVID-19 vaccines: the main pillars of efficacy. Nanomedicine (Lond) 2021;16:2377-87. [PMID: 34632802 DOI: 10.2217/nnm-2021-0250] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Valenzuela-fernández A, Cabrera-rodriguez R, Ciuffreda L, Perez-yanes S, Estevez-herrera J, González-montelongo R, Alcoba-florez J, Trujillo-gonzález R, García-martínez de Artola D, Gil-campesino H, Díez-gil O, Lorenzo-salazar JM, Flores C, Garcia-luis J. Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19. Front Bioeng Biotechnol 2022;10. [DOI: 10.3389/fbioe.2022.1052436] [Reference Citation Analysis]
2 Xu Y, Zhou Z, Brooks B, Ferguson T, Obliosca J, Huang J, Kaneko I, Iwanaga S, Yuda M, Tsuji Y, Zhang H, Luo CC, Jiang X, Kong X, Tsuji M, Tison CK. Layer-by-Layer Delivery of Multiple Antigens Using Trimethyl Chitosan Nanoparticles as a Malaria Vaccine Candidate. Front Immunol 2022;13:900080. [DOI: 10.3389/fimmu.2022.900080] [Reference Citation Analysis]
3 Olivera-ugarte S, Bolduc M, Laliberté-gagné M, Blanchette L, Garneau C, Fillion M, Savard P, Dubuc I, Flamand L, Farnòs O, Xu X, Kamen A, Gilbert M, Rabezanahary H, Scarrone M, Couture C, Baz M, Leclerc D. A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infection. Nanomedicine: Nanotechnology, Biology and Medicine 2022;44:102584. [DOI: 10.1016/j.nano.2022.102584] [Reference Citation Analysis]
4 Zurac S, Vladan C, Dinca O, Constantin C, Neagu M. Immunogenicity evaluation after BNT162b2 booster vaccination in healthcare workers. Sci Rep 2022;12:12716. [PMID: 35882871 DOI: 10.1038/s41598-022-16759-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Bardi G, Neagu M. Moving Forward in Nano-Immune Interactions. Nanomaterials (Basel) 2022;12:2033. [PMID: 35745372 DOI: 10.3390/nano12122033] [Reference Citation Analysis]
6 Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W. Liposomes: structure, composition, types, and clinical applications. Heliyon 2022;8:e09394. [PMID: 35600452 DOI: 10.1016/j.heliyon.2022.e09394] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Chennamchetty VK, Kandi SC, Rao MR. Development of novel vaccines using nanomaterials against COVID-19. Nanotechnological Applications in Virology 2022. [DOI: 10.1016/b978-0-323-99596-2.00012-1] [Reference Citation Analysis]
8 Neagu M, Constantin C, Surcel M. Testing Antigens, Antibodies, and Immune Cells in COVID-19 as a Public Health Topic—Experience and Outlines. IJERPH 2021;18:13173. [DOI: 10.3390/ijerph182413173] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]